Table 1

Relative affinities and potencies of various μ- and δ-opioid receptor agonists for DOR-1 and MOR-1 stably expressed in CHO cells

LigandsDOR-1MOR-1
KiIC50IC50KiIC50IC50
nM nM Ki nM nM Ki
Etorphine6.0  ± 1.30.68  ± 0.050.110.31  ± 0.041.1  ± 0.23.5
DPDPE2.9  ± 0.410.26  ± 0.090.09160  ± 632600  ± 14016
Deltorphin II5.5  ± 1.90.39  ± 0.050.07>10,000>10,000
NTB0.81  ± 0.140.54  ± 0.120.6612  ± 1.321  ± 4.31.7
TIPPψ1.9  ± 0.370.85  ± 0.080.45>10,000>10,000
Oxymorphone250  ± 935.6  ± 0.80.020.82  ± 0.2419  ± 9.223
DAMGO2900  ± 550700  ± 700.241.6  ± 0.354.5  ± 0.62.8
PL017>10,000>10,0006.2  ± 1.412  ± 4.81.9
Naloxone130  ± 2859  ± 150.453.5  ± 0.443.6  ± 0.51.0
CTOP>10,000>10,0000.96  ± 0.3144  ± 2646

Relative affinities of various opioid agonists in CHO cells stably expressing DOR-1 or MOR-1 were determined by competition binding studies using [3H]diprenorphine as radioactive ligand. IC50 values of ligands were obtained from computer analysis of competition curves using Sigma Plot (Jandel, San Rafael, CA).K i values were then calculated using the Cheng-Prusoff equation. Relative potencies were determined by ability of various concentrations of agonists to inhibit 10 μM forskolin-stimulated [3H]cAMP production in CHO cells stably expressing DOR-1 or MOR-1. IC50 values ± S.E. were obtained from computer analysis of dose-response curves using Sigma Plot.